Adaptimmune Therapeutics PLC ADR diskutieren
Adaptimmune Therapeutics PLC ADR
WKN: A14SUX / Name: Adaptimmune / Aktie / Biotechnologie & medizinische Forschung / Small Cap /
0,87 €
2,45 %
Sell Adaptimmune Therapeutics PLC ADR
Lector hat das Wertpapier Adaptimmune Therapeutics PLC ADR in seinem Wikifolio Biotech Pharma gekauft.
Buy Adaptimmune Therapeutics PLC ADR
Buy Adaptimmune Therapeutics PLC ADR
Buy Adaptimmune Therapeutics PLC ADR
Buy Adaptimmune Therapeutics PLC ADR
Buy Adaptimmune Therapeutics PLC ADR
Buy Adaptimmune Therapeutics PLC ADR
Buy Adaptimmune Therapeutics PLC ADR
Buy Adaptimmune Therapeutics PLC ADR
Buy Adaptimmune Therapeutics PLC ADR
Buy Adaptimmune Therapeutics PLC ADR
Buy Adaptimmune Therapeutics PLC ADR
Buy Adaptimmune Therapeutics PLC ADR
Buy Adaptimmune Therapeutics PLC ADR
Buy Adaptimmune Therapeutics PLC ADR
Buy Adaptimmune Therapeutics PLC ADR
Buy Adaptimmune Therapeutics PLC ADR
Buy mit Kursziel 3,5
Buy Adaptimmune Therapeutics PLC ADR
Neueste Beiträge
BiotechBee in Capricor Therapeutics Inc diskutieren